<p>Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD</p>

Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD

Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele

JAMA editors and authors explain the methods underlying clinical research to help students, trainees, and health professionals use the published medical literature to make evidence-based decisions for patients. JAMAevidence is an evidence-based medicine (EBM) resource created and maintained by the JAMA Network to promote the use of EBM to improve patient care.

Share Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele

Sign up to save your podcasts

Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele

Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele

More shows like JAMAevidence Users' Guides to the Medical Literature

JAMA Clinical Reviews

JAMA Author Interviews

The Daily

JAMA Pediatrics Editors' Summary

JAMA Psychiatry Author Interviews

JAMA Neurology Author Interviews

JAMA Oncology Author Interviews

JAMA Cardiology Author Interviews

JAMA Dermatology Author Interviews

JAMA Internal Medicine Author Interviews

JAMA Ophthalmology Author Interviews

JAMA Otolaryngology–Head & Neck Surgery Author Interviews

JAMAevidence The Rational Clinical Examination

JAMA Pediatrics Author Interviews

JAMA Medical News

JAMAevidence Care at the Close of Life

JAMA Network Open Conversations

Freely Filtered, a NephJC Podcast

Coronavirus (COVID-19) Q&A

JAMAevidence JAMA Guide to Statistics and Methods

JAMA Health Forum Conversations

The Economics of Everyday Things